Related Tags >> Phase III Clinical Trial Phase II safety profile

adverse events News

Most Popular adverse events Story

ViroPharma, Wyeth halt HCV study

August 10, 2007 — 5:59am ET

That's not all the bad news for Wyeth today. In yet another blow, the company and its partner ViroPharma have stopped dosing patients with HCV-796, a Phase II hepatitis C drug candidate. The decision Read more...

adverse events Press Releases

Synageva BioPharma Announces Interim Data at 8th Annual Lysosomal Disease Network (LDN) World Symposium
Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychoti
Anacor Pharmaceuticals Announces Positive Preliminary Results from Two Safety Studies of AN2728 and Updates Atopic Dermati
BioMimetic Therapeutics, Inc. to Highlight Product Development Activities at ORS and AAOS Meetings
Global Pharma Selects Semantelli's Compliance Ready Social Listening Platform to Manage Corporate Reputation

Latest Headlines

Supreme Court OKs biotech lawsuits based on adverse events
March 24, 2011
GAO: FDA regulators can't track adverse event reviews
July 21, 2009
Halozyme shares slide on osteoporosis program failure
June 4, 2009
Aastrom halts mid-stage trial after patient death
May 22, 2009
Pharmasset halts Hep B trial after adverse events
April 20, 2009
Safety oversight a rare feature in child drug trials
March 19, 2008
Peregrine reports positive cancer data
March 11, 2008
FDA more friendly to approvable than approved
January 10, 2008
Delcath shares hammered on trial enrollment suspension
October 23, 2007
More good news from RNAi company Isis
October 5, 2007
Positive Phase II results for fungal infection drug
October 5, 2007
FDA, Big Pharma collaborate on genetic tests
September 27, 2007
Exelixis garners $71M in public offering
September 13, 2007
Cancer therapy gets accelerated review at Exelixis
August 23, 2007
ViroPharma, Wyeth halt HCV study
August 10, 2007
Press Release: Theravance Announces Positive Results From Phase 2 Clinical Trial
June 26, 2007
Press Release: BMS Reports on First Phase II Short-Term Study of Dapagliflozin
June 25, 2007
BBC: Britain's Largest Drugs Company Faces Accusation of "Fraud"
January 29, 2007
Press Release: Cephalon Announces Positive Results From Two Phase 3 Clinical Trials Of Fentora
January 10, 2007
Press Release: Genentech Announces Positive Results from Phase II Pertuzumab Study
January 5, 2007

Paid Research Reports

More Research Reports >>

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events